Buy Draxxin Tulathromycin for Cattle and Swine – Veterinary Medicine Information from Equines Vet Care

Draxxin (tulathromycin) is a veterinary prescription injectable medicine containing tulathromycin, a macrolide antibiotic used in approved veterinary applications for cattle and swine. It is designed for use under the supervision of a licensed veterinarian and should always be administered according to official manufacturer instructions and local veterinary regulations.

At Equines Vet Care, we provide reliable veterinary product information for farmers, livestock owners, breeders, and animal healthcare professionals. Our goal is to support responsible animal care by providing accurate information about veterinary medicines, product specifications, and professional usage considerations.

Effective livestock health management requires proper diagnosis, preventive healthcare programs, good nutrition, biosecurity practices, and responsible use of veterinary medicines when recommended by a qualified veterinarian.

Manufacturer-Approved Product Specifications

Product Name

Draxxin Tulathromycin

Active Ingredient

• Tulathromycin

Product Category

• Veterinary prescription antibiotic

Drug Class

• Macrolide antibiotic

Target Species

• Cattle
• Swine

(Approved species may vary depending on country registration.)

Dosage Form

• Sterile injectable solution

Strength

Commonly available as:

• 100 mg/mL tulathromycin injectable solution

Route of Administration

• Administer according to official product labeling and veterinary instructions.

Manufacturer

Draxxin products are manufactured by Zoetis for approved veterinary markets.

Accurate Product Details

Draxxin Tulathromycin contains tulathromycin, an antibiotic belonging to the triamilide subclass of macrolides. It is registered in many markets for specific bacterial respiratory disease indications in cattle and swine.

Important product considerations:

• Prescription veterinary medicine
• Intended for approved livestock species
• Requires veterinary oversight
• Dosage depends on animal weight, species, and veterinary assessment
• Responsible antibiotic use is important for maintaining effectiveness

Veterinarians may consider factors such as disease history, clinical symptoms, and local resistance patterns when selecting antibiotic therapy.

Veterinary Applications

Draxxin products may be approved in some regions for veterinary applications involving susceptible bacterial infections, including certain respiratory disease conditions in cattle and swine.

Approved indications vary by:

• Country
• Regulatory approval
• Animal species
• Product formulation

Always refer to the official package insert or consult a veterinarian before use.

Storage Information

Follow the manufacturer’s official storage instructions.

General storage guidance may include:

• Store at recommended temperatures
• Protect from direct sunlight
• Keep container properly sealed
• Avoid contamination of the product
• Keep away from children
• Do not use after expiration date

Safety Information

• For veterinary use only.
• Use only under veterinary supervision.
• Follow approved dosage instructions.
• Observe withdrawal periods for food-producing animals where applicable.
• Avoid unnecessary antibiotic use.
• Monitor animals for unexpected reactions.
• Keep veterinary medicines stored safely.

Why Choose Equines Vet Care?

Equines Vet Care provides professional veterinary product information and animal healthcare resources for customers worldwide.

Our platform focuses on:

• Accurate veterinary information
• Quality animal healthcare resources
• Trusted product guidance
• Responsible veterinary medicine awareness
• Customer-focused service

We aim to help animal owners and professionals access dependable information about veterinary products.

Frequently Asked Questions

What is Draxxin Tulathromycin?

Draxxin Tulathromycin is a veterinary injectable antibiotic containing tulathromycin, used for approved veterinary applications in cattle and swine under professional supervision.

What is the active ingredient in Draxxin?

The active ingredient is tulathromycin.

What animals is Draxxin approved for?

Draxxin products may be approved for cattle and swine depending on country-specific regulations and product labeling.

Is Draxxin available without veterinary guidance?

No. Veterinary antibiotics should only be used according to professional veterinary advice and approved regulations.

How should Draxxin Tulathromycin be stored?

Store according to the manufacturer’s official instructions provided on the product packaging.

Draxxin Injectable Solution is an antibiotic indicated for the treatment of bovine respiratory disease (BRD), infectious bovine keratoconjunctivitis (IBK) and foot rot in beef and non-lactating dairy cattle and for treatment and control of swine respiratory disease (SRD) in swine. Each ml contains 100 mg tulathromycin. The usual recommended dosage of Draxxin is 2.5 mg per kg (1.1 ml per 100 lbs) body weight, given in the neck. Do not administer more than 10 ml SQ per injection site in cattle. One dose provides up to 7-14 days BRD treatment and control. Do not administer more than 5 ml IM per injection site in swine. Not for use in female dairy cattle 20 months of age or older, or in calves to be processed for veal. Tulathromycin.

BRD – Draxxin Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. IBK – Draxxin Injectable Solution is indicated for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis.

Foot Rot – Draxxin Injectable Solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.

SRD – Draxxin Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, and Mycoplasma hyopneumoniae; and for the control of SRD associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed.